Literature DB >> 20530267

Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Larry H Stanker1, Ana V Serban, Elisa Cleveland, Robert Hnasko, Azucena Lemus, Jiri Safar, Stephen J DeArmond, Stanley B Prusiner.   

Abstract

Prion diseases are fatal, neurodegenerative illnesses caused by the accumulation of PrP(Sc), an aberrantly folded isoform of the normal, cellular prion protein. Detection of PrP(Sc) commonly relies on immunochemical methods, a strategy hampered by the lack of Abs specific for this disease-causing isoform. In this article, we report the generation of eight mAbs against prion protein (PrP) following immunization of Prnp-null mice with rPrP. The eight mAbs exhibited distinct differential binding to cellular prion protein and PrP(Sc) from different species as well as PrP-derived synthetic peptides. Five of the eight mAbs exhibited binding to discontinuous PrP epitopes, all of which were disrupted by the addition of 2-ME or DTT, which reduced the single disulfide bond found in PrP. One mAb F20-29 reacted only with human PrP, whereas the F4-31 mAb bound bovine PrP; the K(D) values for mAbs F4-31 and F20-29 were ~500 pM. Binding of all five conformation-dependent mAbs to PrP was inhibited by 2-ME in ELISA, Western blots, and histoblots. One conformation-dependent mAb F4-31 increased the sensitivity of an ELISA-based test by nearly 500-fold when it was used as the capture Ab. These new conformation-dependent mAbs were found to be particularly useful in histoblotting studies, in which the low backgrounds after treatment with 2-ME created unusually high signal-to-noise ratios.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530267      PMCID: PMC2957185          DOI: 10.4049/jimmunol.0902930

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Determination of antibody affinity by ELISA. Theory.

Authors:  S A Bobrovnik
Journal:  J Biochem Biophys Methods       Date:  2003-09-30

3.  A prion protein epitope selective for the pathologically misfolded conformation.

Authors:  Eustache Paramithiotis; Marc Pinard; Trebor Lawton; Sylvie LaBoissiere; Valerie L Leathers; Wen-Quan Zou; Lisa A Estey; Julie Lamontagne; Marty T Lehto; Leslie H Kondejewski; Gregory P Francoeur; Maria Papadopoulos; Ashkan Haghighat; Stephen J Spatz; Mark Head; Robert Will; James Ironside; Katherine O'Rourke; Quentin Tonelli; Harry C Ledebur; Avi Chakrabartty; Neil R Cashman
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

4.  Analyzing a kinetic titration series using affinity biosensors.

Authors:  Robert Karlsson; Phinikoula S Katsamba; Helena Nordin; Ewa Pol; David G Myszka
Journal:  Anal Biochem       Date:  2005-10-13       Impact factor: 3.365

5.  Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.

Authors:  Gianluca Moroncini; Michela Mangieri; Michela Morbin; Giulia Mazzoleni; Bernardino Ghetti; Armando Gabrielli; Robert Anthony Williamson; Giorgio Giaccone; Fabrizio Tagliavini
Journal:  Neurobiol Dis       Date:  2006-07-28       Impact factor: 5.996

6.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.

Authors:  Jiri G Safar; Michael Scott; Jeff Monaghan; Camille Deering; Svetlana Didorenko; Julie Vergara; Haydn Ball; Giuseppe Legname; Estelle Leclerc; Laura Solforosi; Hana Serban; Darlene Groth; Dennis R Burton; Stanley B Prusiner; R Anthony Williamson
Journal:  Nat Biotechnol       Date:  2002-10-21       Impact factor: 54.908

8.  Transgenic mouse brains for the evaluation and quality control of BSE tests.

Authors:  Wolfgang J Philipp; Darlene Groth; Kurt Giles; Pavel Vodrazka; Heinz Schimmel; Muriel Feyssaguet; Reet Toomik; Pascal Schacher; Awad A Osman; Ingolf Lachmann; Angus Wear; Jean-Noel Arsac; Stanley B Prusiner
Journal:  Biol Chem       Date:  2007-03       Impact factor: 3.915

9.  Measuring prions by bioluminescence imaging.

Authors:  Gültekin Tamgüney; Kevin P Francis; Kurt Giles; Azucena Lemus; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

10.  Prion detection by an amyloid seeding assay.

Authors:  David W Colby; Qiang Zhang; Shuyi Wang; Darlene Groth; Giuseppe Legname; Detlev Riesner; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-20       Impact factor: 11.205

View more
  12 in total

1.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  Characterization of conformation-dependent prion protein epitopes.

Authors:  Hae-Eun Kang; Chu Chun Weng; Eri Saijo; Vicki Saylor; Jifeng Bian; Sehun Kim; Laylaa Ramos; Rachel Angers; Katie Langenfeld; Vadim Khaychuk; Carla Calvi; Jason Bartz; Nora Hunter; Glenn C Telling
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

3.  Identification of I137M and other mutations that modulate incubation periods for two human prion strains.

Authors:  Kurt Giles; Gian Felice De Nicola; Smita Patel; David V Glidden; Carsten Korth; Abby Oehler; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

4.  Conformation-dependent epitopes recognized by prion protein antibodies probed using mutational scanning and deep sequencing.

Authors:  Kyle M Doolan; David W Colby
Journal:  J Mol Biol       Date:  2014-11-07       Impact factor: 5.469

5.  Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.

Authors:  Joel C Watts; Kurt Giles; Ana Serban; Smita Patel; Abby Oehler; Sumita Bhardwaj; Shenheng Guan; Michael D Greicius; Bruce L Miller; Stephen J DeArmond; Michael D Geschwind; Stanley B Prusiner
Journal:  Ann Neurol       Date:  2015-08-25       Impact factor: 10.422

Review 6.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

7.  MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.

Authors:  Fajian Hou; Lijun Sun; Hui Zheng; Brian Skaug; Qiu-Xing Jiang; Zhijian J Chen
Journal:  Cell       Date:  2011-07-21       Impact factor: 41.582

8.  Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.

Authors:  Larry H Stanker; Miles C Scotcher; Alice Lin; Jeffery McGarvey; Stanley B Prusiner; Robert Hnasko
Journal:  Hybridoma (Larchmt)       Date:  2012-10

9.  Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.

Authors:  Susan F Godsave; Holger Wille; Jason Pierson; Stanley B Prusiner; Peter J Peters
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

Review 10.  Prion protein-specific antibodies-development, modes of action and therapeutics application.

Authors:  Tihana Lenac Rovis; Giuseppe Legname
Journal:  Viruses       Date:  2014-10-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.